Welcome — and thank you for being one of the first people to open this. I started BH Leadership Brief for a simple reason: I wanted one quick, easy to read place that pulled together everything new in behavioral health that actually touches my job — and left out everything that doesn't. I spend my days as a leader on the inpatient psych side of behavioral healthcare, where a CMS rule change, a payer's prior-auth shift, or an unfilled psychiatrist line isn't theoretical — it directly shapes my everyday decision making. This is the read I always wanted: one place that pulls the federal and Colorado policy moves, the clinical and pharmacological developments, the technology and AI shifts, and the workforce signals worth knowing, and quietly skips the rest. No filler, no explaining your own job back to you — just the week's intelligence, sorted by what it changes for your operation, in about ten minutes. I'm glad you're here. Let's get into it.

Weekly intelligence for behavioral health leaders: policy, clinical innovation, technology, workforce, and the week ahead.

CMS finalized the FY2027 IPF rule on July 29, and the standardized patient assessment instrument is the provision that will cost you staff hours. The federal per diem base rate rises from $892.87 to $912.40, the ECT payment per treatment from $673.85 to $688.59, and the fixed dollar loss threshold from $39,360 to $40,750, for a 2.3% aggregate increase worth roughly $60 million. CMS deferred the 20% facility-level outlier cap to October 1, 2027 and exempted IPFs running fewer than 50 stays a year. The IPF-PAI is now final: every patient 18 and older gets assessed at admission and discharge regardless of payer, collection starts October 1, 2027, and submission runs through a CMS web application called PARIT or through HL7 FHIR APIs (Federal Register Vol. 91 No. 146, July 31; CMS fact sheet, July 29).

Implication: A 2.3% update won’t cover your wage growth, so the number to model is the outlier cap you now have fourteen months to prepare for. Ask quality what an admission-and-discharge instrument on every adult does to assessment workload, and bring your IT lead, because this is the first CMS quality program to move patient assessment data over FHIR. CMS-relevant.

SAMHSA awarded $73.2 million on July 31, and $11.2 million of it goes to assisted outpatient treatment. The package splits into $44.3 million for the Children’s Mental Health Initiative, $17.6 million to implement the Zero Suicide framework in health systems, and $11.2 million for AOT programs serving adults with serious mental illness. SAMHSA tied the AOT money to the executive order on Ending Crime and Disorder on America’s Streets. Principal Deputy Assistant Secretary Christopher Carroll framed the awards around access and measurable outcomes (HHS, July 31).

Implication: AOT expansion changes who arrives at your door and who you can discharge to. If a provider in your catchment lands one of these awards, your commitment and step-down pathways get rewritten by an organization you do not employ, so find out this month who applied.

Colorado started denying supportive services claims from two provider types yesterday. As of August 1, HCPF denies Provider Type 25 (non-physician practitioner group) and Provider Type 16 (clinic practitioner) claims billed for certain behavioral health supportive and team-based services, in fee-for-service and to the Regional Accountable Entities. Neurological and psychological testing codes leave the behavioral health fee schedule for the Health First Colorado fee schedule on September 1. The revised payment approach for the state’s 19 Comprehensive Safety Net Providers takes effect October 1 (HCPF July 2026 Provider Bulletin B2600540).

Implication: This brief flagged the August 1 date two weeks ago and it landed on schedule. Run a denial report Monday on those two provider types and see what billing did not reroute, because the September 1 fee schedule move is the next one to catch you. Colorado HCPF-relevant.

SAMHSA put out the 2025 NSDUH on July 27, the earliest release in the survey’s history. Among adults, 20.6% (54.6 million) had any mental illness in the past year and 6.9% (18.2 million) had a serious mental illness. The survey drew on more than 60,000 respondents and now carries five years of trend data on the same measures. SAMHSA moved the release up by several months to shorten the lag between collection and policy use (SAMHSA, July 27).

Implication: Eighteen point two million adults with SMI is the denominator every capacity argument you make this budget cycle should start from. Pull the state tables when they post and put Colorado’s SMI prevalence next to your own admission volume. CMS-relevant.

Alzheimer disease psychosis got its first Fast Track designation, and there is still no approved therapy for it. The FDA granted Fast Track to remlifanserin (ACP-204), Acadia’s selective 5-HT2A receptor inverse agonist for hallucinations and delusions in Alzheimer disease psychosis, announced July 20. The mechanism works without direct dopamine blockade, which is the whole point for a population that tolerates antipsychotics badly. Phase 2 RADIANT enrollment is complete with topline results expected September to October 2026, and phase 3 screening is underway (Acadia, July 20; Psychiatric Times).

Operational read: Geriatric units currently manage ADP off-label with agents that carry a boxed mortality warning. Nothing changes on your formulary this quarter, but the September readout is worth a calendar entry, because a non-dopaminergic option would rewrite how long these patients board on a medical floor waiting for a psychiatric bed.

Brexpiprazole improved functioning in schizophrenia patients with hostility and agitation, not only their symptom scores. A post hoc analysis published in the Journal of Clinical Psychiatry in July pooled short- and long-term brexpiprazole trials and separated out adults presenting with hostility and agitation. Functioning improved in that subgroup rather than only the total PANSS movement that usually drives these analyses. The signal held across both the acute and maintenance datasets (Journal of Clinical Psychiatry, July 2026).

Operational read: Hostility and agitation are what drive your restraint numbers and your staff injury reports, and they are usually treated as a dosing problem. A functional outcome in that specific subgroup is an argument your P&T committee can use, so send it to whoever owns your agitation protocol.

Centanafadine posted positive phase 3b data in adults with ADHD and comorbid anxiety, eight days after approval. Otsuka’s nonstimulant met both primary and secondary endpoints in adults carrying both diagnoses, with symptom improvement on the measured scales. The FDA approved centanafadine on July 24 for ADHD in adults and children six and older, which this brief tracked for three issues. The comorbid-anxiety data arrived in the July pipeline recap (Psychiatric Times, July 31).

Operational read: Comorbid anxiety is the reason a lot of your adolescent and young adult ADHD patients were never put on a stimulant in the first place. This is the evidence your prescribers will ask for at the next formulary meeting, so get it in the packet.

Colorado’s restrictions on clinical AI take effect August 12, and they reach licensed clinicians, not only chatbot vendors. House Bill 26-1195, enacted June 3, prohibits AI therapy chatbots and restricts how licensed psychologists, counselors, social workers, marriage and family therapists, and other psychotherapy providers may use AI. The statute leans on the state’s authority to license mental health professionals rather than on consumer protection law, which is what gives it teeth inside your building. Colorado is one of five states that enacted this kind of restriction in 2026 (Becker’s Behavioral Health, July 28).

Implication: Ten days out, your written AI policy needs to name which tools your licensed staff may touch and what human review looks like before a note is signed. Ambient documentation and chart-aware note generation sit inside the scope of a licensing statute, so treat this as a credentialing question, not an IT procurement question. Colorado-relevant.

Maine’s AI therapy prohibition went live July 29, and the country now runs four incompatible regulatory models. Maine treats offering AI therapy without a licensed professional as an unfair trade practice. Illinois, Nevada, Rhode Island, and Vermont bar AI from independently delivering mental health services, Rhode Island’s version starting January 1, 2027, while Utah requires disclosure and New York, California, and Nebraska add crisis-referral and minor-protection duties. The same product can be lawful in one state and carry criminal exposure in another (Becker’s Behavioral Health, July 28; Quartz, July 30).

Implication: If you operate or telehealth across state lines, one AI policy will not hold. Build a per-state matrix now with three columns: what the tool may do, who must review it, and what the patient has to be told.

State legislatures passed 84 AI laws in the first half of 2026, and seven states aimed them at payers. The Transparency Coalition’s 2026 Mid-Year State AI Legislation Report, released July 21, counted 84 new AI laws across 27 states between January and June. Seven states limited how health insurers may use AI in medical authorization decisions, and five prohibited AI chatbot therapy outright. Iowa now requires patient consent before AI records or transcribes a clinical encounter, and Utah specified that AI does not count as a technology upgrade within a clinic’s scope of practice (Transparency Coalition, July 21).

Implication: The payer-side laws are the ones that touch your revenue cycle. If a state limits algorithmic authorization, your concurrent review denials become appealable on process grounds, so tell utilization review to log which denials arrived without a named human reviewer.

Crisis line demand is up 15% year over year while the call centers behind it report staffing shortages. KFF’s fourth-year analysis of 988 counts 23.3 million contacts since July 2022, split into 15.8 million calls, 4.2 million texts, and 3.4 million chats. Monthly volume has cleared 600,000 for the past year and frequently approaches 700,000, with March 2026 volume running 15% above a year earlier and nearly 50% above two years earlier. Twelve states have passed telecom-fee legislation to fund 988 sustainably, most under 45 cents per line (KFF, July 2026).

Workforce read: The crisis line is the front door that decides whether a person reaches you by ambulance or by referral. Understaffed call centers push volume to emergency departments, and emergency departments push it to you, so track your ED-origin admission share against your state’s 988 answer rate.

More than one in five behavioral health facilities reported turnover going up last year, and about half plan to hire more anyway. A national workforce survey found 21.7% of behavioral health facilities saw turnover increase over the previous twelve months, 67.7% held flat, and 10.6% saw it fall. Roughly half expect to add staff in the coming year. Mental health workers carried the highest turnover rates of any category measured (OPEN MINDS, July 16).

Workforce read: Two-thirds holding flat reads like stability until you notice the market simply stopped improving. If you’re in the half planning to hire, you’re bidding against the other half for the same candidates, so check whether your posting-to-offer cycle still runs the way it did in 2024.

The 2026 behavioral health salary benchmark moved 2.48% for licensed counselors, which is below what your competitors are actually paying. The tenth annual Behavioral Health Salary & Benefits Report from Hospital & Healthcare Compensation Service puts the national hourly rate for Licensed Professional Clinical Counselors at $40.57 in 2026, up from $39.59 in 2025. The study covers 501 facilities and programs and 33,602 employees, with breakouts by region, state, CBSA, profit type, and facility type. It also carries turnover and vacancy rates by department and shift differential data (Hospital & Healthcare Compensation Service, 2026).

Workforce read: A 2.48% national move against a 3.2% IPF market basket means the benchmark is lagging your cost curve. Use the CBSA cut rather than the national line when you take a retention case to finance, because Denver metro does not pay the national number.

•      August 7, 8:30 a.m. ET: BLS releases the July Employment Situation. Health care has carried national job growth for most of 2026, and the ambulatory versus hospital split tells you which direction clinical labor is moving before your own recruiters feel it.

•      August 12: Colorado House Bill 26-1195 takes effect, prohibiting AI therapy chatbots and restricting how licensed psychotherapy providers may use AI. Have your written policy and your documented human review step in place before that Wednesday. Colorado-relevant.

•      August 20, 9 a.m. MT: The Colorado BHA Advisory Council meets on its standing third-Thursday cadence, open to the public. Implementation timelines for the CCBHC demonstration and the ASAM Criteria alignment rules are the items worth listening for. Colorado BHA-relevant.

•      September 14: Comments close on the CY2027 Medicare Physician Fee Schedule proposed rule (CMS-1848-P), which carries the Advanced Primary Care Management add-on codes for behavioral health integration and psychiatric Collaborative Care. If you bill CoCM, this is your comment window. CMS-relevant.

•      October 1: FY2027 IPF PPS rates apply to discharges on or after this date, running through September 30, 2027. The 20% outlier cap follows a year later on October 1, 2027, and IPF-PAI collection starts the same day. CMS-relevant.

You have fourteen months to build an admission-and-discharge assessment on every adult patient you treat, and the facilities that start this fall are the ones that will not be paying overtime for it in 2027.

Sources

–    Federal Register, Vol. 91, No. 146, “Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System, Rate Update” (CMS-1847-F), July 31, 2026; CMS fact sheet, July 29, 2026

–    U.S. Department of Health & Human Services, “SAMHSA Awards $73.2 Million for Mental Health Treatment and Suicide Prevention Programs,” July 31, 2026

–    Colorado Department of Health Care Policy & Financing, July 2026 Provider Bulletin (B2600540), supportive services claim edits effective August 1, 2026

–    SAMHSA, “SAMHSA Releases Annual National Survey on Drug Use and Health” (2025 NSDUH), July 27, 2026

–    Acadia Pharmaceuticals news release, “Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer’s Disease Psychosis,” July 20, 2026; Psychiatric Times coverage

–    Journal of Clinical Psychiatry, “Effects of Brexpiprazole on Functioning in Patients With Schizophrenia Who Have Hostility and Agitation Symptoms: Post Hoc Analysis of Short- and Long-Term Trials,” July 2026

–    Psychiatric Times, “July 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News,” July 31, 2026

–    Becker’s Behavioral Health, “5 states restrict AI therapy chatbots in 2026,” July 28, 2026; Colorado House Bill 26-1195, enacted June 3, 2026, effective August 12, 2026

–    Quartz, “U.S. states are all over the map on how to regulate AI therapy chatbots,” updated July 30, 2026

–    Transparency Coalition, 2026 Mid-Year State AI Legislation Report, released July 21, 2026

–    KFF, “988 Enters Its Fourth Year as Demand Grows,” July 2026 (Lifeline data through March 2026 nationally, May 2026 by state)

–    OPEN MINDS, “More Than 20% Of Behavioral Health Facilities Report Higher Turnover; Mental Health Workers Have Highest Rates,” July 16, 2026

–    Hospital & Healthcare Compensation Service, 10th annual Behavioral Health Salary & Benefits Report, 2026

–    U.S. Bureau of Labor Statistics, Employment Situation release schedule; July 2026 data scheduled for August 7, 2026

–    CMS, CY2027 Medicare Physician Fee Schedule proposed rule (CMS-1848-P), comments due September 14, 2026

Make sure to subscribe so you don’t miss the next newsletter and you stay informed on the updates shaping behavioral healthcare in Colorado and the nation.